Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide multiple funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
Característiques principals
EFSD, JDRF and Lilly have established a new programme called EFSD/JDRF/Lilly European Programme in Type 1 Diabetes to encourage new projects aimed at advancing current knowledge in this domain.

The general goals of the Programme are to:
i.) promote the highest quality of basic biomedical and clinical research in Europe and its associated countries applicable to type 1 diabetes;
ii.) expedite the practical application of scientific advances in our understanding of the aetiology, pathogenesis, treatment and prevention of type 1 diabetes and its complications;
iii.) encourage clinical translational research bridging the bench and the bedside;
iv.) increase awareness of type 1 diabetes research throughout Europe.

This year the Programme would particularly welcome projects in the following areas:
  • Research with potential to increase understanding of the natural history, pathogenesis, and/or heterogeneity of human type 1 diabetes;
  • Pancreatic beta cell biology and potential human beta cell regenerative approaches;
  • Pathophysiology of type 1 diabetes autoimmunity with a focus on potential therapeutic targets and autoantigen-specific immunoregulation of type 1 diabetes;
  • Therapies that slow or stop the progression of type 1 diabetes before symptomatic disease or that preserve beta cell function in new onset type 1 diabetes;
  • Biomaterials for implantable, encapsulated beta cell replacement;
  • Automated closed loop artificial pancreas systems and/or its components;
  • Novel or repurposed therapies to improve glycaemic and overall metabolic control in type 1 diabetes:
  • Glucose-responsive insulin:
  • Therapies that prevent progression of diabetic kidney or eye disease in type 1 diabetes.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
    Marta López: mlopez4@imim.es Ext.: 1576
    Carol Barnwell: cbarnwell@imim.es Ext.1670
    Convocatòria (URL)
    http://www.europeandiabetesfoundation.org/index.php/ct-menu-item-5/14-sample-data-articles/220-efsd-jdrf-lilly-european-programme-in-type-1
    Requisits
    Applications for an EFSD research grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
    Dotació
    Research will be supported through the award of grants, each of up to Euro 100,000.
    Applicants who have a funding requirement larger than that specified above are also invited to apply to this Programme, particularly if this relates to a clinical research project: in this case, the relevant financial requirements not exceeding €400,000 should be indicated and well justified in the budget section of the application form.
    Durada
    The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application.

    Arxius

    Arxiu
    Application Form